This article is a correction to:
T lymphocyte cell: A pivotal player in lung cancer
Yanan Wu
Meng Yuan
Chenlin Wang3
Yanfei Chen
Jiandong Zhang- 1Department of Oncology, the First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Shandong Key Laboratory of Rheumatic Disease and Translational Medicine, Shandong Lung Cancer Institute, Jinan, China
- 2Department of Oncology, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, China
- 3School of Clinical Medicine, Weifang Medical University, Weifang, China
- 4Medical Integration and Practice Center, Cheeloo College of Medicine, Shandong University, Jinan, China
A Corrigendum on
T lymphocyte cell: A pivotal player in lung cancer
by Wu Y, Yuan M, Wang C, Chen Y, Zhang Y and Zhang J (2023) . 14:1102778. doi: 10.3389/fimmu.2023.1102778
In the published article, there was an error in affiliations 1 and 2. Instead of “1Department of Oncology, Shandong First Medical University, Jinan, China, 2Department of Oncology, the First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan, Shandong, China” it should be “1Department of Oncology, the First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Shandong Key Laboratory of Rheumatic Disease and Translational Medicine, Shandong Lung Cancer Institute, Jinan, China, 2Department of Oncology, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, China”.
In the published article, there was an error in the Funding statement. Instead of the following: “This research was funded by Shandong Natural Science Foundation [ZR2021LSW023 and ZR2022MH111].” The correct Funding statement appears below.
Funding
“This research was funded by Shandong Natural Science Foundation [ZR2021LSW023 and ZR2022MH111] and the Fundamental Research Funds of Shandong University.”
The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: lung cancer, T lymphocyte, immunotherapy, tumor microenvironment, immunosuppression
Citation: Wu Y, Yuan M, Wang C, Chen Y, Zhang Y and Zhang J (2023) Corrigendum: T lymphocyte cell: A pivotal player in lung cancer. Front. Immunol. 14:1166352. doi: 10.3389/fimmu.2023.1166352
Received: 15 February 2023; Accepted: 16 February 2023;
Published: 21 February 2023.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2023 Wu, Yuan, Wang, Chen, Zhang and Zhang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Yan Zhang, eWFuLnpoYW5nQHNkdS5lZHUuY24=; Jiandong Zhang, SmlhbmRvbmd6aGFuZzE2NUAxNjMuY29t